Towards Healthcare

Separation Systems for Commercial Biotechnology Companies Strategic Expansion Initiatives

Date : 29 January 2026

Who are the Top Vendors in Separation Systems for Commercial Biotechnology Market and What are Their Offerings?

Thermo Fisher Scientific Inc.

Headquarter: Massachusetts, U.S.
Separation Systems for Commercial Biotechnology: HPLC systems, centrifuges, and mass spectrometers

Danaher Corporation

Headquarter: Washington, D.C., U.S.
Separation Systems for Commercial Biotechnology: Filtration and AKTA chromatography systems

Merck KGaA

Headquarter: Darmstadt, Germany
Separation Systems for Commercial Biotechnology: Pellicon tangential flow filtration and Mobius single-use bioreactors and purification systems

Sartorius AG

Headquarter: Gottingen, Germany
Separation Systems for Commercial Biotechnology: Cross filtration systems, single-use separation technologies, and chromatography skids

Agilent Technologies, Inc.

Headquarter: California, U.S.
Separation Systems for Commercial Biotechnology: Liquid chromatography and gas chromatography

Bio-Rad Laboratories, Inc.

Headquarter: California, U.S.
Separation Systems for Commercial Biotechnology: NGC chromatography systems

Waters Corporation

Headquarter: Massachusetts, U.S.
Separation Systems for Commercial Biotechnology: Ultraperformance liquid chromatography and mass spectrometry

Repligen Corporation

Headquarter: Massachusetts, U.S.
Separation Systems for Commercial Biotechnology: XCell alternating tangential flow systems

Shimadzu Corporation

Headquarter: Kyoto, Japan
Separation Systems for Commercial Biotechnology: Prominence and Nexera HPLC and UHPLC systems

Eppendorf SE

Headquarter: Hamburg, Germany
Separation Systems for Commercial Biotechnology: High-speed laboratory centrifuges and bioprocess controllers

Market Value Chain Analysis

R&D

  • The R&D of the separation systems for commercial biotechnology focuses on the development of single-use technologies, AI-driven automation, and continuous bioprocessing.
  • Key players: Merck KGaA, Thermo Fisher Scientific Inc., and Danaher Corporation.

Clinical Trials and Regulatory Approvals

  • Process validation, safety, purity, chemical compatibility, and viral clearance are evaluated in the clinical trials and regulatory approvals of the separation systems for commercial biotechnology.
  • Key players: Sartorius AG, Merck KGaA, Danaher Corporation.

Packaging and Serialization

  • The packaging and serialization of separation systems for commercial biotechnology involves the use of tamper-evident, sterile barrier materials and GS1-compliant DataMatrix codes to ensure product traceability and integrity.
  • Key players: Antares Vision Group, Optel Group, Stevanato Group.

Distribution to Hospitals, Pharmacies

  • The good distribution practices (GDP) compliant networks and specialized healthcare logistics help in the distribution of the separation systems to the hospital and pharmacies.
  • Key players: Cencora, McKesson Corporation, Cardial Health.

Patient Support and Services

  • The specialty pharmacy programs and digital health platforms offering injection therapy, education, and financial assistance are provided in the patient support and services of the separation systems for commercial biotechnology.
  • Key players: Cencora, Cardial Health, CVS Specialty.

Market Growth

The global separation systems for commercial biotechnology market size was estimated at USD 29.57 billion in 2025 and is predicted to increase from USD 31.27 billion in 2026 to approximately USD 56.72 billion by 2035, expanding at a CAGR of 6.84% from 2026 to 2035.

Separation Systems for Commercial Biotechnology Market Trends and Growth (2026)

Recent Developments in the Market

  • In January 2026, India’s first fully integrated agarose gel electrophoresis system, that is GelGenius, was launched by the Department of Biotechnology (DBT)-Institute of Life Sciences (ILS) bioincubator, with a goal to make molecular biology more accessible and affordable.
  • In May 2025, the Cytek Aurora™ Evo system, which is an advanced full-spectrum flow cytometer, was launched by Cytek Biosciences, Inc. to improve the cell analysis capabilities, data quality, efficiency, streamline workflows, and enhance its applications in immunology and cell biology.

Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com